Iimpawu zeMatriki eziPhambili eziPhambili

  • 01 IChwepheshe leMveliso yeMveliso

    eli lilly

    I-China ingaba yinto yesibini yehlabathi lemarike enkulu, emva kwe-United States, ngo-2015, ngokwemali ye-IMS Health.

    Ubungakanani bemarike ngo-2011: i-$ 63.9 yezigidigidi

    Abemi: 1.3 billion

    I-Makeup Makeup: Ehluke kakhulu kubakhi abangaphezu kwama-3 000 basekhaya, iindidi ezinkulu kunye namayeza emveli.

    I-Branded vs. Generic: Izizukulwana zimelele malunga neepesenti ezingama-64 zeemarike ngexabiso, kunye neziyobisi ezingaphezu kwe- 26 ezimele malunga neepesenti ezingama-26.

    Ukusasazwa: Inkqubo yokuthengiswa kwemarike yendawo yesithili esebenzisa abahluleli abaninzi.

    Abathengi Abakhulu: Izibhedlele (ama-56 ekhulwini), ii-pharmacy (iipesenti ezingama-24), amaziko empilo asekuhlaleni (ama-20 ekhulwini)

    Imithombo: IMS Health, PharmaVentures, Espicom

  • 02 Brazil Iimveliso zeMveliso zeMveliso

    Ubungakanani bemarike ngo-2011: i-$ 22.7 yezigidigidi

    Abemi: 206 yezigidi

    I-Makeup Makeup: Iimveliso ezikhoyo ngoku zilawula i-market yemveliso yezobisi yaseBrazil kodwa ilizwe likhula ngokukhawuleza kwishishini elikhokelwa yi-EMS, Aché, Eurofarma, ne-Hypermarcas.

    I-Branded vs. Generic: I- generics enezibhengezo (iipesenti ezingama-70) ikhokelela kwimarike, ilandelwa yile-counter-counter (iipesenti ezili-17) kunye ne-patented (12 ekhulwini). Icandelo le-generic yaseBrazil lelona likhulu phakathi kweentlanga zaseLatin America.

    Ukusabalalisa: Iinkampani ezincinci zilawula ukusabalalisa kodwa kunabantu abangaphezu kwama-3,000.

    Abathengi abaPhambili : ii- Pharmacy kunye neentengiso (iipesenti ezingama-71), izibhedlele (iipesenti eziyi-8)

    Ukukhula okuqikelelweyo ngo-2015: i- 7 ukuya kwi-12 ekhulwini

    Imithombo: IMS Health, PharmaVentures, Epsicon

  • 03 I-Asia Pacific Pacific

    I-pharmas ehlabathini lonke ithathe umdla kummandla olandelayo ukuphucula kwimeko yokulawula, ukunyuka kwemali, ukunyusa imisebenzi kunye namathuba okuveliswa kwemvumelwano.

    Ubungakanani bemarike ngo-2011: i -18.2 yezigidigidi zamaRandi

    Abemi: 464 yezigidi ezidibeneyo

    I-Makeup Makeup: i- GlaxoSmithKline, i-Pfizer, i-Sanofi-Aventis, i-Ranbaxy Laboratories kunye ne-Takeda Amachiza asebenzayo kummandla.

    I-Branded vs. Generic: IVietnam ine-market generic (ipesenti ezingama-90 zebonke), ngelixa i-Market yeSingapore iyingama-20 ewonke. Icandelo elingaphezulu kwe-counter liyakwandisa kulo lonke ummandla.

    Ukusabalalisa: Abapashi abakhulu baquka iZuellig Pharma

    Abathengi abaPhambili : Uhluleke phakathi kwamazwe

    Ukukhula okuqikelelweyo ngo-2015: i- 7 kuya kwi-10 ekhulwini

    Imithombo: IMS Health, PharmaVentures, RNCOS

  • 04 IRashiya yeMakethe yeMveliso

    Iintlobo ezininzi zeemali zanyusa ukutshala imali kwi- farma yeRussia ye-pharma ngo-2011 kubandakanywa noNovartis, owaqala ukwakhiwa kweziko lokuvelisa eSt. Petersburg kunye ne-AstraZeneca eyaqala ukukwakha isityalo esitsha kwindawo yaseKaluga.

    Ubungakanani bemarike ngo-2010: i-$ 18.7 yezigidigidi

    Abemi: 142 yezigidi

    I-Makeup Makeup: Amaninzi amazwe anamaqela amaninzi asebenza ngaphakathi

    I-Branded vs. Generic: Imarike yaseRashiya ilawulwa yii-generics ezivelisiweyo zendawo kodwa kukho imfuno ekhulayo ye-generics engaphezulu kwiinkampani ezizweni.

    Ulwabiwo-mali: Ngo-2010, abapapashi abaphezulu aba-10 balawulwa ngamaphesenti angama-90 okusasazwa.

    Abathengi Abakhulu: Izibhedlele, imibutho yokunakekela, i-arhente karhulumente, abathengisi beziyobisi.

    Ukukhula okuqikelelweyo ngo-2015: i- 10 ukuya ku-12 ekhulwini

    Imithombo: i- Espicom, i-IMS Health, ishishini laseRussia-yaseMelika, i-DSM Group

  • 05 India Market Mveliso

    Sekudala inkokheli yehlabathi kwiimarike zonyango eziqhelekileyo kunye nabakhiqizi beyeza-3 500 abathengisa nge-$ 10 billion ngonyaka ukuya kumazwe angaphezu kwe-100, iNdiya inenjongo yokwandisa ukuthengisa kwayo kwezinye iimarike ezikhulayo, e-United States naseYurophu. UDkt. Reddy, omnye wabakhiqizi abakhulu be-India, sele esele enza izinto ezinkulu kwiimakethe zase-US.

    Ikhontrakthi yokuveliswa kwezilwanyana zamachiza egunyazisiweyo kunye nokusingatha izilingo zeklinikhi kwizizwe eziziintlobo zezinye iindawo zokukhula ngaphakathi kwimarike yase-India.

    Ubungakanani bemarike ngo-2011: i-$ 15.7 billion

    Abemi: 1.2 billion

    I-Makeup Makeup: Iimveliso eziphambili ze-generics kwiimarike eziphuhlisiweyo kuquka i-US neYurophu.

    I-Branded vs. Generic: I- generic ebonakalayo ibonisa iipesenti ezingama-90 zokuthengisa izidakamizwa zonyango, izidakamizwa ezingaphezulu kwee-counter zimela iipesenti ezili-16 zexabiso elithengiswayo.

    Ukusabalalisa: I- India ithembele kwinkqubo yokusabalalisa i-agent ye-clearing nokuthumela (CFA). Nangona inani labaphasisi kunye neeprosemmenti zentengiso landa, kusekho ukungabi nakwaneleyo ekuhanjisweni, ngakumbi kwimimandla yasemaphandleni.

    Abaxhasi abaPhambili : ii- Pharmacy (iipesenti ezingama-70), izibhedlele (iipesenti ezingama-30)

    Ukukhula okulinganiselweyo ngo-2015: i- 12 ukuya kuma-16 ekhulwini

    Imithombo: IMS Health, Epsicon, iingxelo zeNkampani

  • 06 Turkey Iimveliso zeMveliso

    I-Turkey inomashishini otywala ngokukhawuleza kunye nowona mkhulu phakathi kweentlanga zaseMiddle East. Iinkampani zamanye amazwe zinabo malunga neepesenti ezingama-80 zendawo zokuvelisa iimveliso zeplastiki. Ngo-Ephreli 2012 u-Amgen wathola iipesenti ezingama-95.6 zee-Mustafa Nevzat Pharmaceuticals (MN), inkampani yaseTurkey eyayibanjwe ngasese i-$ 700 yezigidi. I-Turkey inokulawula ngokuthe ngqo ukulawula intengo kwaye isebenzisa malunga ne-$ 50 nganye kwiimveliso zonyango ngonyaka, ngokubhekiselele ku-Egon Zehnder International, i-consultancy ye-industry.

    Ubungakanani bemarike ngo-2011: i-$ 11.6 yezigidigidi

    I-Makeup Makeup: malunga nama-85 asekuhlaleni nakwabakhi belizwe

    I-Branded vs. Generic: Izizukulwana zimela malunga neepesenti ezingama-50 zevolumu kunye neepesenti ezingama-35 zexabiso. I-over-the-counter imele ipesenti ezili-11 zeemarike ezipheleleyo.

    Ukusabalalisa: Abasasazo ababini abaphezulu, i-Hedef kunye ne-Selcuk Ecza, iipesenti ezingama-70 zokwabiwa ngexesha ii-co-ops zengingqi zinesabelo sepesenti eziyi-15.

    Abathengi abaPhambili : Uhlula phakathi kwee-pharmacy, izibhedlele kunye neeklinikhi

    Ukukhula okulinganiselweyo ngo-2015: i- 10 kuya ku-14 ekhulwini

    Imithombo: IMS Health, PharmaVentures, ingxelo zeenkampani